Latest Research and Advances in Treating Severe Uncontrolled Asthma

October 16, 2024

Severe uncontrolled asthma poses a significant challenge in clinical practice, affecting millions of patients worldwide and leading to considerable morbidity and healthcare costs. Despite the availability of standard treatments, many patients find themselves trapped in a cycle of persistent symptoms and frequent exacerbations. However, recent advancements in research and innovative treatment options are providing new hope for the effective management of this complex condition.


Understanding Severe Uncontrolled Asthma

Severe uncontrolled asthma is characterized by persistent respiratory symptoms and exacerbations despite high-dose inhaled corticosteroids and additional controller medications. Patients often present with a range of symptoms, including wheezing, shortness of breath, chest tightness, and cough. Identifying the underlying mechanisms contributing to uncontrolled asthma is essential for developing targeted therapies.


Biologic Therapies: A Game Changer

Biologic therapies have significantly transformed the management landscape for severe uncontrolled asthma by specifically targeting inflammatory pathways involved in its pathophysiology. These therapies are particularly advantageous for patients with eosinophilic or allergic asthma. Key biologics include:


  1. Omalizumab: Omalizumab targets immunoglobulin E (IgE) and has shown efficacy in reducing exacerbations and improving asthma control in patients with allergic asthma. Recent studies have demonstrated its effectiveness in various age groups, including children and adolescents.
  2. Mepolizumab and Reslizumab: These monoclonal antibodies target interleukin-5 (IL-5), which plays a crucial role in eosinophil maturation and activation. Clinical trials have shown that these therapies significantly reduce eosinophil counts, leading to fewer exacerbations and improved lung function.
  3. Benralizumab: Benralizumab also targets IL-5 but uniquely induces eosinophil apoptosis. Studies have indicated that it provides a rapid onset of action and sustained improvement in asthma control.
  4. Tezepelumab: This newer biologic targets thymic stromal lymphopoietin (TSLP), a cytokine involved in the initiation of allergic inflammation. Recent research has shown that Tezepelumab can reduce asthma exacerbations across a broad patient population, regardless of eosinophil levels, making it a promising option for a wider range of severe asthma patients.


Molecule Therapies


In addition to biologics, small molecule therapies are gaining traction as effective treatments for severe uncontrolled asthma, particularly for patients who do not respond adequately to traditional inhaled medications or biologics. These therapies work by targeting specific inflammatory pathways involved in asthma pathophysiology, providing a more tailored approach to management. For example, Brensocatib, an oral drug that inhibits neutrophil serine proteases, has shown promise in reducing airway inflammation and improving lung function in clinical trials. Additionally, leukotriene receptor antagonists, such as montelukast, are commonly used to block the action of leukotrienes—potent mediators of inflammation that contribute to bronchoconstriction and mucus production. The convenience of oral administration and the ability to target distinct molecular mechanisms make small molecule therapies an exciting avenue in asthma treatment. Ongoing research continues to explore their efficacy and safety, with the potential to significantly enhance outcomes for patients struggling with severe uncontrolled asthma.


Discussion on Severe Uncontrolled Asthma at the 2024 KY Bourbon and Roses Symposium


The 2024 KY Bourbon and Roses Symposium featured a panel discussion on severe uncontrolled asthma, addressing the latest challenges and advancements in its management. Esteemed experts in the field shared their first-hand experience and cases. Attendees had the opportunity to engage in meaningful dialogue about the complexities of diagnosing and managing severe asthma and explored the impact of emerging research on clinical strategies. This session aimed to equip healthcare professionals with practical knowledge and tools to enhance patient outcomes, ultimately fostering a collaborative environment dedicated to improving the lives of those affected by severe uncontrolled asthma.


 

Stay tuned for more helpful tips from the Snot Force Alliance on how to provide better care for patients, and join our force today!

Doctor and patient reviewing a sinus ct scan beside a medical scan display
October 13, 2026
Learn how ENT doctors can approach complex cases when standard treatment algorithms fall short, using collaboration, research, and personalized airway care.
September 22, 2026
Inflammatory airway diseases can impact a patient's quality of life. Untreated conditions leave patients struggling to breathe, coughing regularly, and feeling unwell for months at a time. Airway disease management has undergone significant changes in recent years. Treating airway diseases has become increasingly complex, despite improvements in methodologies and technologies. In rural and underserved regions, many patients lack access to specialty care. Key Takeaways: Providing high-quality care to patients with airway disease requires collaboration across specialties. It is important to expand rural ENT access and access to multidisciplinary clinics. Clinicians in rural communities can improve patient outcomes through collaborations and with creative solutions that expand airway care. The Need for Multidisciplinary Airway Care Airway diseases affect multiple systems of the body and thus are treated by different types of physicians. Allergists, primary care doctors, pulmonologists, and ENT physicians all play a role in caring for patients with airway conditions. Physicians who can facilitate multidisciplinary care can improve diagnostic accuracy while also helping to ensure better patient outcomes. Challenges in Rural and Underserved Communities Rural ENT access is spotty at best. Many rural areas lack specialty physicians and often, patients must travel long distances to tertiary medical centers where they receive care. As a result, patients with limited transportation options may experience delays in diagnosis and care. Sometimes, these specialty care disparities can leave primary care providers to manage complex airway conditions on their own. In areas where insurance coverage is limited, and referral networks are fragmented, patients may struggle with their conditions without treatment at all. The Consequences of These Limitations Delays in diagnosis and treatment mean poor management of chronic conditions and increased reliance on treatment from acute care settings. Under this system, patients become frustrated as they lean on ineffective treatment methods. Methods for Expanding Access There are many methods for expanding access to patients in rural and underserved areas. Telehealth Airway Care The use of telehealth treatment has significantly expanded in recent years. With telehealth tools, hybrid care models combine in-person and virtual visits. This same technology also connects doctors, bringing together specialists and community clinicians. Regional Centers of Excellence Multidisciplinary airway centers have proven effective for helping patients access specialty care. Airway centers make it easier to streamline referrals in complex cases. These airway centers can serve larger geographic areas by setting up outreach clinics in surrounding communities. Collaborative Networks Partnerships and collaborations between physicians are key to ensuring that primary care providers in underserved areas have access to resources and information. Supporting Rural Physicians There are many ways to support rural physicians. Snot Force has committed to build networks for physicians, helping to ensure the dissemination of information across specialties and practice settings. We facilitate collaboration between disciplines to promote innovation in care for underserved communities. We're bringing doctors together to break down specialty care disparities and improve rural ENT access and information. Our research collaborative depends on many medical professionals to participate, and we're always looking for more physicians to join the force. To learn more, contact Snot Force today .
doctors discussing how AI helps
September 10, 2026
Explore the ethical considerations of AI-guided airway care, including clinical judgment, patient consent, bias, safety, data privacy, and validation.
Unified airway awareness logo
August 25, 2026
Discover how biologics, multidisciplinary care, and precision medicine are shaping the future of unified airway care and chronic airway disease management over the next five years.
anatomy-of-paranasal-sinuses-and-trachea-airway-3d-illustration
August 11, 2026
Explore emerging tools in functional airway assessment, including quantitative CT, airway imaging, airflow modeling, and advanced sinus diagnostics shaping the future of ENT and airway care.
A doctor reviewing a patient chart on a clipboard, representing clinical decision-making for chronic
July 28, 2026
Compare surgery, biologics, and medical management for chronic sinusitis. Learn how clinicians choose the best treatment for CRS and nasal polyps.
Woman in a face mask holding a flower to her nose, illustrating smell loss from chronic sinusitis.
July 16, 2026
Learn why smell loss in chronic sinusitis may signal severe airway disease, nasal polyps, or eosinophilic inflammation, and explore today's treatment options.
doctors training each other
July 7, 2026
Learn why interdisciplinary training in CRS, asthma, biologics, and airway inflammation is essential for preparing clinicians to diagnose and manage complex airway disease.
a group of physicians in a meeting
June 26, 2026
Learn how standardized communication across ENT, allergy, pulmonology, and GI specialties improves care coordination, teamwork, and patient outcomes.
participants-learning-new-ultrasound-techniques-on-medical-congress
May 26, 2026
Discover how translational airway research improves real-world patient care through collaboration, innovation, and evidence-based sinus treatment. Learn how Snot Force helps physicians bridge the gap between airway science and clinical practice.